| Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial MJ Davies, R Bergenstal, B Bode, RF Kushner, A Lewin, TV Skjøth, ... Jama 314 (7), 687-699, 2015 | 1004 | 2015 |
| Current and future therapies for type 1 diabetes BJ von Scholten, FF Kreiner, SCL Gough, M von Herrath Diabetologia 64, 1037-1048, 2021 | 103 | 2021 |
| Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial F Kreiner, H Galbo Arthritis research & therapy 12, 1-9, 2010 | 98 | 2010 |
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled … M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ... The Lancet Diabetes & Endocrinology 9 (4), 212-224, 2021 | 95 | 2021 |
| Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica F Kreiner, H Langberg, H Galbo Arthritis & Rheumatism 62 (12), 3768-3775, 2010 | 84 | 2010 |
| Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients JG Jespersen, A Nedergaard, S Reitelseder, UR Mikkelsen, ... PLoS One 6 (3), e18090, 2011 | 70 | 2011 |
| Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trials AR Kahkoska, MS Geybels, KR Klein, FF Kreiner, N Marx, MA Nauck, ... Diabetes, Obesity and Metabolism 22 (9), 1537-1547, 2020 | 69 | 2020 |
| Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives FF Kreiner, JM Kraaijenhof, M von Herrath, GKK Hovingh, ... Expert Review of Clinical Immunology 18 (4), 377-389, 2022 | 42 | 2022 |
| Elevated muscle interstitial levels of pain-inducing substances in symptomatic muscles in patients with polymyalgia rheumatica F Kreiner, H Galbo Pain 152 (5), 1127-1132, 2011 | 32 | 2011 |
| Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica F Kreiner, H Galbo Scandinavian journal of rheumatology 39 (5), 402-408, 2010 | 21 | 2010 |
| Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials TF Dejgaard, BJ von Scholten, E Christiansen, FF Kreiner, L Bardtrum, ... Diabetes, Obesity and Metabolism 23 (12), 2752-2762, 2021 | 18 | 2021 |
| The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: From randomised trials to clinical practice BJ von Scholten, FF Kreiner, S Rasmussen, P Rossing, T Idorn Therapeutic Advances in Endocrinology and Metabolism 13, 20420188221112490, 2022 | 16 | 2022 |
| Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment FF Kreiner, H Galbo Arthritis research & therapy 14, 1-10, 2012 | 14 | 2012 |
| Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity MH Friedrichsen, L Endahl, FF Kreiner, R Goldwater, M Kankam, ... Molecular Metabolism 78, 101801, 2023 | 13 | 2023 |
| Glucagon/GLP-1 receptor co-agonist NNC9204-1177 reduced body weight in adults with overweight or obesity but was associated with safety issues M Friedrichsen, L Endahl, FF Kreiner, R Goldwater, M Kankam, S Toubro, ... Medrxiv, 2022.06. 02.22275920, 2022 | 12 | 2022 |
| Multicomponent plasmid protects mice from spontaneous autoimmune diabetes PP Pagni, J Chaplin, M Wijaranakula, JD Wesley, J Granger, J Cracraft, ... Diabetes 71 (1), 157-169, 2022 | 12 | 2022 |
| Current state of antigen-specific immunotherapy for type 1 diabetes FF Kreiner, BJ von Scholten, K Coppieters, M von Herrath Current Opinion in Endocrinology, Diabetes and Obesity 28 (4), 411-418, 2021 | 12 | 2021 |
| Obesity-related Kidney Disease: current understanding and future perspectives FF Kreiner, PA Schytz, HJL Heerspink, BJ von Scholten, T Idorn Biomedicines 11 (9), 2498, 2023 | 7 | 2023 |
| Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes B Yesildag, J Mir-Coll, A Neelakandhan, CB Gibson, NR Perdue, C Rufer, ... Clinical Immunology 244, 109118, 2022 | 5 | 2022 |
| The potential of glucagon-like peptide-1 receptor agonists in heart failure FF Kreiner, GKK Hovingh, BJ von Scholten Frontiers in physiology 13, 983961, 2022 | 5 | 2022 |
